Objective:To evaluate the efficacy of DynaCT-assisted DEB-TACE in the treatment of primary liver cancer and its clinical advantages compared to traditional transcatheter arterial chemoembolization(TACE).Methods:Sixty-...Objective:To evaluate the efficacy of DynaCT-assisted DEB-TACE in the treatment of primary liver cancer and its clinical advantages compared to traditional transcatheter arterial chemoembolization(TACE).Methods:Sixty-four patients with primary liver cancer were enrolled as the study subjects.They were randomly divided into two groups according to the number table method.展开更多
文摘Objective:To evaluate the efficacy of DynaCT-assisted DEB-TACE in the treatment of primary liver cancer and its clinical advantages compared to traditional transcatheter arterial chemoembolization(TACE).Methods:Sixty-four patients with primary liver cancer were enrolled as the study subjects.They were randomly divided into two groups according to the number table method.
